17.3 C
New York
Wednesday, October 30, 2024

Eli Lilly misses third-quarter profit amid soaring demand for weight-loss drug By Reuters

Eli Lilly misses third-quarter profit amid soaring demand for weight-loss drug By Reuters

(Reuters) – Eli Lilly (NYSE:) missed Wall Street estimates for third-quarter profit on Wednesday, even as demand for its weight-loss drug soared, hurt by higher manufacturing and acquisition-related costs.

The company earned $1.18 per share on an adjusted basis for the quarter ended Sept.30, compared with analysts’ average estimate of $1.47, according to LSEG data.



Source link

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles